Mode
Text Size
Log in / Sign up

Oncology

1421 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Retrospective analysis finds sarcopenia associated with shorter disease-free survival in pancreatic neuroendocrine tumor patients
Oncology Cohort
Retrospective analysis finds sarcopenia associated with shorter disease-free survival in pancreatic neuroendocrine tumor patients Low muscle mass linked to shorter disease-free survival in pancreatic tumor patients
This retrospective cohort study included 86 patients who underwent curative-intent resection for pancreatic neuroendocrine tumors.
Low muscle mass before surgery was linked to shorter disease-free survival in patients with pancreatic neuroendocrine tumors, though this li…
Review Examines Artificial Intelligence Guided Acupuncture Decision Making and Treatment
Oncology Sys. Review
Review Examines Artificial Intelligence Guided Acupuncture Decision Making and Treatment AI Helps Doctors Choose Acupuncture Points With More Accuracy
This review explores the integration of artificial intelligence into acupuncture decision making and treatment protocols.
Smart machines now help doctors choose acupuncture points more accurately while monitoring safety during treatment sessions for better patie…
Mini review discusses translational hurdles and classification limitations in tumor-host interface research
Oncology Sys. Review
Mini review discusses translational hurdles and classification limitations in tumor-host interface research New review highlights hurdles in treating complex tumors
This mini review addresses the limitations of traditional pathological classification and the translational hurdles of TME-directed therapie…
A fresh look at tumor treatment reveals big challenges in understanding how cancer cells interact with their environment and why current met…
Absence of antiviral therapy and multiple chemotherapeutic agents increase HBV reactivation risk after TACE
Oncology Cohort
Absence of antiviral therapy and multiple chemotherapeutic agents increase HBV reactivation risk after TACE No Antiviral Meds Raise Liver Cancer Risks After Chemo
This retrospective cohort study of 168 HBsAg-positive HCC patients undergoing TACE found that absence of prophylactic antiviral therapy (OR …
Many liver cancer patients with hepatitis B face avoidable risks during chemo—because they’re not getting a simple antiviral pill most alrea…
NTCP Models Underestimate Radiation Pneumonitis Risk in Lung Cancer Patients
Oncology Cohort
NTCP Models Underestimate Radiation Pneumonitis Risk in Lung Cancer Patients New tool better predicts lung damage from radiation therapy
This cohort study of 580 lung cancer patients found that QUANTEC and Appelt NTCP models systematically underestimated radiation pneumonitis …
A new risk model more accurately predicts lung injury after modern radiation therapy for lung cancer, helping doctors tailor safer treatment…
Independent and P2S supine breast MRI tumor contrast compared to prone MRI in surgical guidance
Oncology Cohort
Independent and P2S supine breast MRI tumor contrast compared to prone MRI in surgical guidance Supine breast MRI matches prone for tumor contrast in surgery planning
This cohort study evaluated subjects undergoing breast MRI for surgical guidance comparing independent supine and P2S supine imaging against…
A new study finds supine breast MRI can match prone imaging for tumor contrast, potentially improving surgical guidance.
Modified thin-slab volume rendering improves diagnostic performance for pneumonic-type lung cancer and inflammatory pneumonia
Oncology Cohort
Modified thin-slab volume rendering improves diagnostic performance for pneumonic-type lung cancer and inflammatory pneumonia New Imaging Trick Tells Cancer and Pneumonia Apart
This retrospective cohort study evaluated modified thin-slab volume rendering (tsVR) with densitometry-derived thresholds against convention…
Doctors can now tell aggressive lung cancer apart from pneumonia more accurately using a simple tweak to CT scans that highlights subtle dif…
Deep Learning MRI Models Predict Treatment Response in Hepatocellular Carcinoma Following Transarterial Chemoembolization
Oncology Cohort
Deep Learning MRI Models Predict Treatment Response in Hepatocellular Carcinoma Following Transarterial Chemoembolization AI Models Predict Liver Cancer Treatment Response Better Than Standard Scores
This cohort study evaluated AI models using gadoxetic acid–enhanced MRI in 160 patients with Barcelona Clinic Liver Cancer stage A or B hepa…
Artificial intelligence using MRI scans predicted how patients with liver cancer would respond to treatment more accurately than standard cl…
Adjuvant chemotherapy improves overall survival in resectable stage I-III duodenal adenocarcinoma patients
Oncology Cohort
Adjuvant chemotherapy improves overall survival in resectable stage I-III duodenal adenocarcinoma patients After Surgery, This Extra Step May Extend Survival in Rare Cancer
This retrospective cohort study evaluated 98 patients with resectable stage I-III duodenal adenocarcinoma at two Chinese institutions.
After surgery for duodenal cancer, adding chemotherapy may nearly double survival time, but larger trials are still needed.
Systematic review and meta-analysis of robotic versus laparoscopic surgery for rectal cancer
Oncology Meta-analysis
Systematic review and meta-analysis of robotic versus laparoscopic surgery for rectal cancer Robotic surgery shows lower urinary retention for rectal cancer patients in a review of 6,121 cases
This systematic review and meta-analysis evaluated robotic versus laparoscopic surgery in 6121 rectal cancer patients with 12.0 months of fo…
A review of 6,121 rectal cancer patients found robotic surgery led to less urinary retention than laparoscopic surgery, though other functio…
Systematic review and meta-analysis compares subcutaneous versus intravenous PD-1/PD-L1 inhibitors for solid tumors
Oncology Meta-analysis
Systematic review and meta-analysis compares subcutaneous versus intravenous PD-1/PD-L1 inhibitors for solid tumors Subcutaneous shots match intravenous drugs for cancer survival and response rates in solid tumors
This systematic review and meta-analysis of 1243 patients with solid tumors found no significant difference in overall survival, progression…
A large review found that giving cancer drugs under the skin works just as well as the traditional vein injection for patients with solid tu…
Abexinostat showed a 69.5% objective response rate in relapsed follicular lymphoma patients
Oncology Phase II
Abexinostat showed a 69.5% objective response rate in relapsed follicular lymphoma patients New Drug Shrinks Stubborn Lymphoma Tumors After Other Treatments Fail
This single-arm, multi-center phase 2 study evaluated abexinostat in 90 patients with relapsed or refractory follicular lymphoma who had rec…
A new treatment is helping some patients with stubborn lymphoma shrink tumors and stay in control for over a year, even after other therapie…